10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0001354488-11-002762`
Period End Date	20110630
Filing Date	20110815
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	gthp-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 60 Cash Flow Statement 64

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.34M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$230.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$373.00K	USD	Point-in-time
Preferred stock, Authorized	`PreferredStockSharesAuthorized`	5,000.00	shares	Point-in-time
Preferred stock, Authorized	`PreferredStockSharesAuthorized`	5,000.00	shares	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $38 at June 30, 2011 and December 31, 2010	`AccountsReceivableNet`	$85.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $38 at June 30, 2011 and December 31, 2010	`AccountsReceivableNet`	$149.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$30.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$22.00K	USD	Point-in-time
Preferred stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.38M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$37.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$64.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	100,000.00	shares	Point-in-time
Capitalized cost of internally developed software for internal use	`CapitalizedComputerSoftwareNet`	$409.00K	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	100,000.00	shares	Point-in-time
Capitalized cost of internally developed software for internal use	`CapitalizedComputerSoftwareNet`	$299.00K	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	47,299.00	shares	Point-in-time
Other Assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	48,491.00	shares	Point-in-time
Other Assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$200.00K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$804.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	48,491.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	47,299.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$536.00K	USD	Point-in-time
Total assets	`Assets`	$3.92M	USD	Point-in-time
Total assets	`Assets`	$3.32M	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$24.00K	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$25.00K	USD	Point-in-time
Notes payable	`NotesPayable`	-	USD	Point-in-time
Notes payable	`NotesPayable`	$162.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$340.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$614.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$937.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$915.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilities`	$885.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilities`	$773.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$655.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$332.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.89M	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebt`	$17.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebt`	$31.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.80M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.91M	USD	Point-in-time
Series A convertible preferred stock, $.001 par value; 5,000 shares authorized, no shares outstanding as of June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Series A convertible preferred stock, $.001 par value; 5,000 shares authorized, no shares outstanding as of June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 Par value; 100,000 shares authorized, 48,491 and 47,299 shares issued and outstanding as of June 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Common stock, $.001 Par value; 100,000 shares authorized, 48,491 and 47,299 shares issued and outstanding as of June 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$79.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$80.03M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$-104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$-104.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-78.44M	USD	Point-in-time
Total Guided Therapeutics stockholders' equity	`StockholdersEquityBeforeNoncontrollingInterest`	$1.01M	USD	Point-in-time
Total Guided Therapeutics stockholders' equity	`StockholdersEquityBeforeNoncontrollingInterest`	$306.00K	USD	Point-in-time
Non-controlling interest	`NoncontrollingInterest`	$104.00K	USD	Point-in-time
Non-controlling interest	`NoncontrollingInterest`	$104.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$410.00K	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$3.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$3.92M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Service revenue	`Revenues`	$1.63M	USD	2 Qtrs
Service revenue	`Revenues`	$1.68M	USD	2 Qtrs
Service revenue	`Revenues`	$805.00K	USD	1 Quarter
Service revenue	`Revenues`	$913.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.31M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$897.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$619.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$490.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$120.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$71.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$78.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$44.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.28M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$802.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$708.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.47M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$2.29M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$1.40M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$1.34M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$2.90M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-628.00K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-485.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.23M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-531.00K	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$7.00K	USD	1 Quarter
Other income	`OtherIncome`	-	USD	2 Qtrs
Other income	`OtherIncome`	$44.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-1.30M	USD	2 Qtrs
Interest expense	`InterestExpense`	$-28.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$-41.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-18.00K	USD	1 Quarter
Loss from operations	`IncomeLossFromContinuingOperations`	$-1.93M	USD	2 Qtrs
Loss from operations	`IncomeLossFromContinuingOperations`	$-559.00K	USD	1 Quarter
Loss from operations	`IncomeLossFromContinuingOperations`	$-1.22M	USD	2 Qtrs
Loss from operations	`IncomeLossFromContinuingOperations`	$-496.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-559.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.22M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.93M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-496.00K	USD	1 Quarter
Preferred stock dividends	`DividendsPreferredStock`	$-1.70M	USD	2 Qtrs
Preferred stock dividends	`DividendsPreferredStock`	-	USD	1 Quarter
Preferred stock dividends	`DividendsPreferredStock`	-	USD	1 Quarter
Preferred stock dividends	`DividendsPreferredStock`	-	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAttributableToCommonStockholders`	$-3.63M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAttributableToCommonStockholders`	$-559.00K	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAttributableToCommonStockholders`	$-496.00K	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAttributableToCommonStockholders`	$-1.22M	USD	2 Qtrs
Basic and diluted net loss per share attributable to common stockholders	`NetIncomeLossPerShareAttributableToCommonStockholdersBasicAndDiluted`	$0.03	USD	2 Qtrs
Basic and diluted net loss per share attributable to common stockholders	`NetIncomeLossPerShareAttributableToCommonStockholdersBasicAndDiluted`	$0.02	USD	1 Quarter
Basic and diluted net loss per share attributable to common stockholders	`NetIncomeLossPerShareAttributableToCommonStockholdersBasicAndDiluted`	$0.01	USD	1 Quarter
Basic and diluted net loss per share attributable to common stockholders	`NetIncomeLossPerShareAttributableToCommonStockholdersBasicAndDiluted`	$0.13	USD	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	26,969.00	shares	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	32,520.00	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	48,159.00	shares	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	48,464.00	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-559.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.22M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.93M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-496.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$8.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.00K	USD	2 Qtrs
Amortization and accretion of deferred financing costs, notes and warrants	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Amortization and accretion of deferred financing costs, notes and warrants	`AmortizationOfFinancingCosts`	$1.09M	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$251.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$470.00K	USD	2 Qtrs
Gain on debt renegotiated	`GainOnDebtRenigotiated`	$-23.00K	USD	2 Qtrs
Gain on debt renegotiated	`GainOnDebtRenigotiated`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-64.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-131.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$57.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-22.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$323.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$278.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$153.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-41.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$8.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$2.08M	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$309.00K	USD	2 Qtrs
Net cash (used in) provided by operations	`NetCashProvidedByUsedInContinuingOperations`	$147.00K	USD	2 Qtrs
Net cash (used in) provided by operations	`NetCashProvidedByUsedInContinuingOperations`	$-913.00K	USD	2 Qtrs
Additions to capitalized software	`CapitalizedComputerSoftwareAdditions`	$-110.00K	USD	2 Qtrs
Additions to capitalized software	`CapitalizedComputerSoftwareAdditions`	$-11.00K	USD	2 Qtrs
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-35.00K	USD	2 Qtrs
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-86.00K	USD	2 Qtrs
Net cash (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-145.00K	USD	2 Qtrs
Net cash (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-97.00K	USD	2 Qtrs
Proceeds from issuance of convertible notes payable to former debt holders - related parties	`ProceedsFromIssuanceOfConvertibleNotesRelatedParty`	$101.00K	USD	2 Qtrs
Proceeds from issuance of convertible notes payable to former debt holders - related parties	`ProceedsFromIssuanceOfConvertibleNotesRelatedParty`	-	USD	2 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromWarrantExercises`	$195.00K	USD	2 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Payments on notes and loans payable	`PaymentsOfLoanCosts`	$-8.00K	USD	2 Qtrs
Payments on notes and loans payable	`PaymentsOfLoanCosts`	$-62.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$93.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$133.00K	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-925.00K	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$143.00K	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.34M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$230.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$373.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.34M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$230.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$373.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$8.00K	USD	2 Qtrs
Cash paid for Interest	`InterestPaid`	$1.00K	USD	2 Qtrs
Conversion of preferred stock into common stock	`ConversionOfPreferredStockIntoCommonStock`	$1.96M	USD	2 Qtrs
Conversion of preferred stock into common stock	`ConversionOfPreferredStockIntoCommonStock`	-	USD	2 Qtrs
Dividends payable in the form of preferred stock converted into common stock	`DividendsPayablePreferredStockConvertedToCommonStock`	$1.82M	USD	2 Qtrs
Dividends payable in the form of preferred stock converted into common stock	`DividendsPayablePreferredStockConvertedToCommonStock`	-	USD	2 Qtrs
Conversion of notes payable into common stock	`ConversionOfNotesPayableToCommonStock`	$27.00K	USD	2 Qtrs
Conversion of notes payable into common stock	`ConversionOfNotesPayableToCommonStock`	$9.35M	USD	2 Qtrs
Deemed dividends in the form of preferred stock and redeemable convertible preferred stock	`DividendsPreferredStockAndRedeemableConvertiblePreferredStock`	-	USD	2 Qtrs
Deemed dividends in the form of preferred stock and redeemable convertible preferred stock	`DividendsPreferredStockAndRedeemableConvertiblePreferredStock`	$1.70M	USD	2 Qtrs
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	$23.00K	USD	2 Qtrs
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.